{
  "file_id": "file_7d05f563b50b",
  "source_path": "C:\\IntelliCV\\data\\JVCV - 61603.pdf",
  "extracted_at": "2025-08-10T16:25:41.363644",
  "text": " \n  \nCand idate No.:   61603  \n \n \nPERSONAL DETAI LS \n  \nLocati on:   Munich  \n \n \nQUALI FICATI ONS  \n \n12.10.2016 – 29.01.2020  Ludwig -Maximilians -University of Munich  \nFaculty of Biology, Martinsried Biocentre MSc in Biology, 1,44 (very good)  \n \n03.06.2019 – 01.12.2019 Center fo r Translational Cancer Research, Technical University of Munich, (Klinikum \nRechts der Isar Munich, Germany) Prof. Roland Rad  \nMaster’s thesis project: “Design and Production of Next Generation Activating Transposons For In v ivo \nTransposon Screens”. Develop ment of a new screening tool for discovery of oncogenes  \n \n01.09.2012 – 30.06.2016  Taras Shevchenko National University of Kyiv, Ukraine ESC Institute of Biology, \nDepartment of Biophysics BSc in Biology  \n \n \nCAREER SUMMARY  \n \n03.08.2020  – Present   \n  \nCand idate No.:   61603  \n \n \nPERSONAL DETAI LS \n  \nLocati on:   Munich  \n \n \nQUALI FICATI ONS  \n \n12.10.2016 – 29.01.2020  Ludwig -Maximilians -University of Munich  \nFaculty of Biology, Martinsried Biocentre MSc in Biology, 1,44 (very good)  \n \n03.06.2019 – 01.12.2019 Center fo r Translational Cancer Research, Technical University of Munich, (Klinikum \nRechts der Isar Munich, Germany) Prof. Roland Rad  \nMaster’s thesis project: “Design and Production of Next Generation Activating Transposons For In v ivo \nTransposon Screens”. Develop ment of a new screening tool for discovery of oncogenes  \n \n01.09.2012 – 30.06.2016  Taras Shevchenko National University of Kyiv, Ukraine ESC Institute of Biology, \nDepartment of Biophysics BSc in Biology  \n \n \nCAREER SUMMARY  \n \n03.08.2020  – Present Company  \n \nSales Manager  \n● Managed full -cycle enterprise sales from prospecting to lead qualification, presentation, negotiation up to deals \nclosure  \n● Achieved clean track record in meeting and exceeding sa les goals  \n● Landed over 3.9 million EUR in revenue from personally closed  deals  \n● Gained successful opportunity conversion rate of 42%  \n \n01.02.2020 – 01.05.2020  – Previous Company  \n \n● Buil t a database of cancer biomarkers and corresponding drugs for person alized precision medicine  \n● Analysed clinical trials and performed literature review: FDA, EMA, NCCN, ASCO, ESMO and RUSSCO \nguidelines  \n● Allied with a forefront clinics and labs in Russia for practice exchange  \n \n02.01.2018 – 30.04.2018   \nUniversity of Alb erta Katz Group Centre for Pharmacy and Health Research (Edmonton, Canada) Research \nAssistant (Awarded UARE grant)  \n● Researched the applicability of anticancer drugs Imatinib, Pazopanib and Sun itinib for Cerebral Malaria \ntreatment  \n \n \nSKILLS  \n \n● Languages: English – C1, G erman – B2, Ukrainian & Russian - native  \n ● Excellent skills in CRM and quotation generating software (e.g. Microsoft 365, CLQ, CLO)  \n● Excellent  understanding of in vitro / in vivo pharmacology  and toxicology  \n● Knowledge of GL P, GMP and GCP quality assurance guides  \n● Effective business communication. Public speaking and presenting skills  \n● Good command for research and reports writing  \n● Driving License  \n \n \nPERSONALI TY \n \n● Easy and eager learner, seeking continu ous improvement  \n● A relationship builder, honouring  long-term commitments and finding resolution in conflict situations  \n● Proactive life position and positive approach towards life and people  \n \n \nFor further i nformati on please contact Thomas -Jan Johnston  on 01695 570 696  or emai l tomj@johnston -\nvere.co.uk  \n \n \n \n ",
  "emails": [],
  "phones": [
    "01.12.2019",
    "01.05.2020",
    "01.02.2020"
  ],
  "names": [
    "Driving License",
    "Translational Cancer",
    "Taras Shevchenko"
  ],
  "work_history": [],
  "skills": []
}